NCT03001284 Multiple Sclerosis Produces Cardiovascular Subclinical Dysfunction Status UNKNOWN Phase N/A
NCT02994121 Prospective Investigation of Multiple Sclerosis in the Three Rivers Region Status RECRUITING Phase N/A
NCT02992847 Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/) Status UNKNOWN Phase N/A
NCT02987621 Can Transcranial Direct Current Stimulation Improve Ambulation and Fatigue Resistance in People With MS? Status COMPLETED Phase NA
NCT02980042 Safety of Switching From Rituximab to Ocrelizumab in MS Patients Status COMPLETED Phase PHASE3
NCT02970370 Demographics, Clinical and Paraclinical Characteristics of Multiple Sclerosis in Egypt Status COMPLETED Phase N/A
NCT02967380 Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases Status TERMINATED Phase NA
NCT02966808 Retrospective Observational Study About Long-term Effect of Fampridine in Patients With Multiple Sclerosis Status UNKNOWN Phase N/A
NCT02965170 Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MS Status COMPLETED Phase N/A
NCT02960984 Neurorehabilitation on Upper Limb and on Fatigue in Multiple Sclerosis Status UNKNOWN Phase NA
NCT02952911 Monitoring of Multiple Sclerosis (MS) Participants With the Use of Digital Technology (Smartphones and Smartwatches) - A Feasibility Study Status COMPLETED Phase NA
NCT02949908 MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS) Status TERMINATED Phase N/A
NCT02947906 Plantar Pressure Distribution in Patient With Multiple Sclerosis Status UNKNOWN Phase N/A
NCT02939859 Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions Status WITHDRAWN Phase PHASE1
NCT02939079 Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients Status COMPLETED Phase PHASE2/PHASE3
NCT02937285 National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple Sclerosis Status COMPLETED Phase PHASE3